These steps give your body time to adjust and can make side effects easier to manage
#tristargrp Work Cited (n.d.)
The injectable GLP-1 RAs liraglutide 3 mg once daily and semaglutide 2.4 mg once weekly have both gained a licence for weight loss, alongside lifestyle management, in obese/overweight people without T2D (SmPC, 2023b
This multi-pronged approach increases your chances for achieving faster, sustainable weight loss
McGee explains, If we need to stay on a low dose for a long time or increase temporarily to get back on track with weight loss goals, we can do that and monitor progress over the long term
This association between liver disease and DPP-4 has been confirmed in other studies, showing higher plasma levels (85, 86) as well as higher hepatic Dpp4 expression (87) in the patients compared to healthy individuals